|
Donner B, et al. Direct conversion from oral morphine to transdermal
fentanyl. Pain, 1996. 64:527-534.
Porter J, Jick H. Addiction rare in patients treated with narcotics.
N Engl J Med, 1980. 302:123.
Foley KM. The "decriminalization" of cancer pain.
IN: Advances in pain research and therapy, vol 11: Drug treatment of cancer
pain in a drug oriented society. Hill CS , Fields WS (eds), New York,
Raven Press 1989.
Perry S. Heidrich. Management of pain during debridement: A survey
of US burn units. Pain, 1982. 13:267.
Robins LN, David DH, Nurco DN. How permanent was Vietnam drug addiction?
Am J Public Health, 1974. 64:38.
Inturrisi CE, Umans JG. Meperidine biotransformation and central
nervous system toxicity in animals and humans. . IN Foley KM, Inturrissi
CE (eds): Advances in pain research and therapy, vol 8: Opioid analgesics
in the management of clinical pain, p 143. New York , Raven Press, 1986.
Simopoulos TT, et al. Use of meperidine in patient-controlled analgesia
and the development of normeperidine toxic reactions. Archives of
Surgery, 2002. 137:84-88.
Bruera E, Brenneis C, Michaud M, et al. Use of the subcutaneous
route for the administration of narcotics in patients with cancer pain.
Cancer, 1988. 62:407-411.
Storey P. Subcutaneous infusion for control of cancer symptoms. J Pain
Symptom Manage. 1990. 5:33-41.
Levy, MH. Pharmacologic treatment of cancer pain.
New Engl J Med, 1996. 335(15):1124-32.
|
